CHRONIC MYELOID LEUKEMIA – FROM HOPELESSNESS TO SUCCESS IN TREATMENT THE EXPERIENCE OF THE NNCRM AND THE WORLD RECOGNITION OF THE ACHIEVEMENTS OF UKRAINIAN HEMATOLOGISTS

Abstract

Since 2001, the Department of Radiation OncoA hematology and Stem Cell Transplantation of the National Research Center for Radiation MediA cine, headed by MD, Dr Med. Sci., Prof. Iryna Dyagil carry on with the problem of chronic myeloid leukemia (CML), which until 2000 was considered an incurable disease. Diagnosis and treatment were limited, and therefore the survival of such patients was only 3–5 years. In 2001, targeted drugs of tyroA sine kinase inhibitors were registered (TKI) in the world, and a rapid development in both diagnosis and treatment of this disease began. And already the first data showed impressive results of treatment, which allowed 85 % of patients with CML to survive, live and, having achieved a deep molecular remisA sion, be healthy.